Skip to main content

Nations Fail to Agree on Treaty on Preventing Next Pandemic

Medically reviewed by Carmen Pope, BPharm. Last updated on May 28, 2024.

By Robin Foster HealthDay Reporter

TUESDAY, May 24, 2024 -- Following two years of tough negotiations, efforts to craft a global treaty to help countries fight future pandemics have failed, the World Health Organization has acknowledged.

"WHO Member States have ended intensive negotiations aimed at strengthening global capacities to respond to future pandemics and outbreaks in the wake of the COVID-19 pandemic, and agreed to submit outcomes of their work for consideration by the upcoming World Health Assembly, starting Monday," the WHO said in a statement released Friday.

“Over the past two years, WHO Member States have dedicated enormous effort to rise to this challenge posted by COVID-19 and respond to the losses it caused, including at least 7 million lives lost,” WHO Director General Dr. Tedros Adhanom Ghebreyesus said in the statement. “While great progress was made during these negotiations, there are challenges still to overcome. We need to use the World Health Assembly to re-energize us and finish the job at hand, which is to present the world with a generational pandemic agreement.”

Back in 2021, member countries asked the WHO to oversee negotiations to figure out how the world might better share resources and stop future viruses from spreading rapidly around the globe.

On Friday, Roland Driece, co-chair of WHO’s negotiating board for the agreement, said the World Health Assembly meeting this week will have to chart the way forward.

“We will try everything -- believing that anything is possible -- and make this happen because the world still needs a pandemic treaty,” Ghebreyesus said, the Associated Press reported. “Because many of the challenges that caused a serious impact during COVID-19 still exist.”

The co-chairs of the treaty process didn’t specify what caused the collapse of the treaty, but diplomats have said vast differences remain over the sharing of information about pathogens that emerge and the sharing of technologies to fight them, the AP reported.

The latest draft had proposed that the WHO should get 20% of the production of pandemic-related products like tests, treatments and vaccines, and it urged countries to disclose their deals with private companies.

Earlier this month, U.S. Republican senators sent a letter urging President Biden not to sign off on a treaty that is essentially "supercharging the WHO."

Meanwhile, many developing countries said it’s unfair that they might be expected to provide virus samples to help develop vaccines and treatments, but then be unable to afford them, the AP reported.

Precious Matsoso, the other co-chair of WHO’s negotiating board for the treaty, told the AP there was still a chance to reach agreement on a treaty.

“We will make sure that this happens, because when the next pandemic hits, it will not spare us,” she said.

Sources

  • World Health Organization, news release, May 24, 2024
  • Associated Press

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Heart Experts Have Tips on Staying Safe in the Summer Heat

FRIDAY, July 5, 2024 -- As Americans brace themselves for another summer of brutal heat and humidity, the American Heart Association (AHA) warns that heart patients need to take...

Fourth Dairy Worker Infected With Bird Flu, but CDC Says Public Risk Still Low

WEDNESDAY, July 3, 2024 -- Amid an ongoing outbreak of bird flu in dairy cows, a fourth case of H5N1 avian flu has been confirmed in another dairy worker, U.S. health officials...

Gratitude May Bring Longer Life

WEDNESDAY, July 3, 2024 -- People who are grateful for what they have tend to live longer, a new study reports. Older women who scored highest on a questionnaire measuring...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.